MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹458 Cr | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr |
What is the latest Cash Flow from Operating Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹458 Cr |
| Mar2025 | ₹207 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹99 Cr |
How is Cash Flow from Operating Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹458 Cr | 121.68 | |
| Mar2025 | ₹207 Cr | -10.30 | |
| Mar2024 | ₹230 Cr | -2.95 | |
| Mar2023 | ₹237 Cr | 139.19 | |
| Mar2022 | ₹99 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,794.7 Cr | 1.1% | 21.3% | 97.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.1% |
21.3% |
97.6% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses